|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,840.00 JPY | +3.97% |
|
+25.55% | -19.73% |
| 02-19 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 238M | - | - | - | - | - |
| 66.56B | |||||
| 56.51B | |||||
| 42.98B | |||||
| 40.46B | - | ||||
| 31.91B |
- Stock Market
- Stocks
- 4894 Stock
- Charts Cuorips Inc.
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
